– Ecstasy labelled a ‘breakthrough therapy’ for patients with post-traumatic stress disorder by the FDA:
ILLICIT drug ecstasy is one step away from being licensed in the US for its effectiveness in treating post-traumatic stress disorder.
The US Food and Drug Administration (FDA) has determined that illicit drug ecstasy is a “breakthrough therapy” in post-traumatic stress disorder (PTSD) treatment.
Methylenedioxymethamphetamine (MDMA), commonly referred to as ecstasy, could now have a faster pathway to pharmaceutical approval in the US, reports Science Alert .
* * *
PayPal: Donate in USD
PayPal: Donate in EUR
PayPal: Donate in GBP